Rising Insulin Costs Addressed at Senate Hearing on Drug Prices – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889
In a congressional hearing held on Capitol Hill today, the damaging impact of rising insulin prices was the centerpiece of a larger discussion on rising drug costs in the United States.
The Senate Finance Committee hearing, held by Chairman Senator Charles Grassley, R-Iowa, was the first of a series of hearings that will focus on drug pricing.
Kathy Sego, who is the mother of a child with insulin-dependent diabetes; Douglas Holtz-Eakin, PhD, who is president of the American Action Forum; Mark E. Miller, PhD, who is vice president of health care at Laura and John Arnold Foundation; and Peter B. Bach, MD, MAPP, who is director of Memorial Sloan Kettering Center for Health Policy and Outcomes all were part of the discussion.